{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:37:41Z","timestamp":1789702661057,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.vaccine.2003.07.010","type":"journal-article","created":{"date-parts":[[2003,9,12]],"date-time":"2003-09-12T17:29:37Z","timestamp":1063387777000},"page":"503-510","source":"Crossref","is-referenced-by-count":79,"title":["IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-\u03b3 and TNF-\u03b1 dependent pathway"],"prefix":"10.1016","volume":"22","author":[{"given":"Cristina T.","family":"Fonseca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana F.A.","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 B.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio C.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2003.07.010_BIB1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0001-706X(00)00122-4","article-title":"The global status of schistosomiasis and its control","volume":"77","author":"Chitsulo","year":"2000","journal-title":"Acta Trop."},{"issue":"3","key":"10.1016\/j.vaccine.2003.07.010_BIB2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1128\/CMR.2.3.250","article-title":"Immunopathology of Schistosoma mansoni infection","volume":"2","author":"Boros","year":"1989","journal-title":"Clin. Microbiol. Rev."},{"issue":"5","key":"10.1016\/j.vaccine.2003.07.010_BIB3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00436-001-0588-x","article-title":"Chemotherapeutic approaches to schistosomes: current knowledge and outlook","volume":"88","author":"Harder","year":"2002","journal-title":"Parasitol. Res."},{"issue":"1","key":"10.1016\/j.vaccine.2003.07.010_BIB4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1590\/S0074-02761998000700013","article-title":"Schistosomiasis vaccine development: progress and prospects","volume":"93","author":"Bergquist","year":"1998","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"2","key":"10.1016\/j.vaccine.2003.07.010_BIB5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/S0074-02761995000200017","article-title":"Schistosomiasis vaccine development: approaches and prospects","volume":"90","author":"Bergquist","year":"1995","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"2","key":"10.1016\/j.vaccine.2003.07.010_BIB6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0001-706X(02)00048-7","article-title":"Blueprint for schistosomiasis vaccine development","volume":"82","author":"Bergquist","year":"2002","journal-title":"Acta Trop."},{"issue":"7","key":"10.1016\/j.vaccine.2003.07.010_BIB7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1471-4922(02)02301-2","article-title":"Schistosomiasis: from risk assessment to control","volume":"18","author":"Bergquist","year":"2002","journal-title":"Trends Parasitol."},{"issue":"13","key":"10.1016\/j.vaccine.2003.07.010_BIB8","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1016\/S0021-9258(18)92995-9","article-title":"A 14 kDa Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid-binding proteins","volume":"266","author":"Moser","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vaccine.2003.07.010_BIB9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1590\/S0074-02762001000900019","article-title":"r-Sm14\u2013pRSETA efficacy in experimental animals","volume":"96","author":"Ramos","year":"2001","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"4502","key":"10.1016\/j.vaccine.2003.07.010_BIB10","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1126\/science.7233238","article-title":"Immunization of baboons with Schistosoma mansoni cercariae attenuated by gamma irradiation","volume":"212","author":"Stek","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2003.07.010_BIB11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0065-308X(08)60048-2","article-title":"The radiation-attenuated vaccine against schistosomes in animal models: paradigm for human vaccine?","volume":"39","author":"Coulson","year":"1997","journal-title":"Adv. Parasitol."},{"issue":"4","key":"10.1016\/j.vaccine.2003.07.010_BIB12","first-page":"466","article-title":"A role for CD4+ but not CD8+ T cells in immunity to Schistosoma mansoni induced by 20 krad-irradiated and Ro 11-3128-terminated infections","volume":"67","author":"Vignali","year":"1989","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.vaccine.2003.07.010_BIB13","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.4049\/jimmunol.149.11.3654","article-title":"Monoclonal antibody to IFN-gamma modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae","volume":"149","author":"Smythies","year":"1992","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.vaccine.2003.07.010_BIB14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2567.1996.465550.x","article-title":"Impaired immunity and altered pulmonary response in mice with a disrupted interferon-\u03b3 receptor gene exposed to the irradiated Schistosoma mansoni vaccine","volume":"87","author":"Wilson","year":"1996","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2003.07.010_BIB15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4049\/jimmunol.162.1.345","article-title":"Optimal vaccination against Schistosoma mansoni requires the induction of both B cell and IFN-\u03b3 dependent effector mechanisms","volume":"162","author":"Jankovic","year":"1999","journal-title":"J. Immunol."},{"issue":"6603","key":"10.1016\/j.vaccine.2003.07.010_BIB16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","article-title":"Functional diversity of helper T lymphocytes","volume":"383","author":"Abbas","year":"1996","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.vaccine.2003.07.010_BIB17","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1128\/IAI.70.9.4833-4840.2002","article-title":"Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy","volume":"70","author":"Katae","year":"2002","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.vaccine.2003.07.010_BIB18","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1128\/IAI.66.9.4503-4506.1998","article-title":"Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice","volume":"66","author":"Letscher-Bru","year":"1998","journal-title":"Infect. Immun."},{"issue":"5144","key":"10.1016\/j.vaccine.2003.07.010_BIB19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.7904381","article-title":"The adjuvant effect of interleukin-12 in a vaccine against Leishmania major","volume":"263","author":"Afonso","year":"1994","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.vaccine.2003.07.010_BIB20","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.4049\/jimmunol.154.9.4701","article-title":"IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinofilia","volume":"154","author":"Wynn","year":"1995","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.vaccine.2003.07.010_BIB21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0264-410X(98)00152-2","article-title":"Induction of a protective immunity against Schistosoma mansoni with ovalbumin-coupled Sm37-5 coadsorbed with granulocyte-macrophage colony stimulating factor (GM-CSF) or IL-12 on alum","volume":"17","author":"Argiro","year":"1999","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2003.07.010_BIB22","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/S0264-410X(99)00532-0","article-title":"IL-18 potentiates the adjuvant properties of IL-12 in the induction of a strong Th1 type immune response against a recombinant antigen","volume":"18","author":"Eberl","year":"2000","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2003.07.010_BIB23","first-page":"41","article-title":"Human IgG1 and IgG3 recognition of Schistosoma mansoni 14 kDa fatty acid-binding protein","volume":"22","author":"Brito","year":"2000","journal-title":"Parasite Immunol."},{"issue":"4","key":"10.1016\/j.vaccine.2003.07.010_BIB24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1017\/S0031182000086248","article-title":"The infection of laboratory hosts with cercariae of Schistosoma mansoni and recovery of adult worms","volume":"55","author":"Smythies","year":"1965","journal-title":"Parasitology"},{"issue":"4","key":"10.1016\/j.vaccine.2003.07.010_BIB25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF00932188","article-title":"Comparative analysis of hepatic, pulmonary, and intestinal granuloma formation around freshly laid Schistosoma japonicum eggs in mice","volume":"79","author":"Hirata","year":"1993","journal-title":"Parasitol. Res."},{"issue":"9","key":"10.1016\/j.vaccine.2003.07.010_BIB26","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.4049\/jimmunol.157.9.4068","article-title":"IL-12 enhances vaccine induced immunity to Schistosoma mansoni by augmenting both humoral and cell mediated immune response against the parasite","volume":"157","author":"Wynn","year":"1996","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.vaccine.2003.07.010_BIB27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0169-4758(00)01788-9","article-title":"Defining a schistosomiasis vaccination strategy\u2014is it really Th1 versus Th2?","volume":"16","author":"Wynn","year":"2000","journal-title":"Parasitol. Today"},{"issue":"1","key":"10.1016\/j.vaccine.2003.07.010_BIB28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1073\/pnas.93.1.269","article-title":"A Schistosoma mansoni fatty acid-binding protein, Sm14, is a potential basis of a dual-purpose anti-helminthes vaccine","volume":"93","author":"Tendler","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.vaccine.2003.07.010_BIB29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0008-8749(89)90011-7","article-title":"Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin-1 in proliferative response","volume":"121","author":"Grun","year":"1989","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.vaccine.2003.07.010_BIB30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.iy.08.040190.001511","article-title":"Lymphokine control of in vivo immunoglobulin isotype selection","volume":"8","author":"Finkelman","year":"1990","journal-title":"Annu. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.vaccine.2003.07.010_BIB31","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/eji.1830201010","article-title":"Induction of antibody synthesis by CD4+ T cells: IL-4 is essential for induction of antigen specific antibody response by Th2 but not Th1 clones","volume":"20","author":"DeKruyff","year":"1990","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.vaccine.2003.07.010_BIB32","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-3083.2000.00710.x","article-title":"CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein","volume":"51","author":"Brito","year":"2000","journal-title":"Scand. J. Immunol."},{"issue":"8","key":"10.1016\/j.vaccine.2003.07.010_BIB33","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.4049\/jimmunol.163.8.4489","article-title":"TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated schistosome vaccine","volume":"163","author":"Street","year":"1999","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.vaccine.2003.07.010_BIB34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0952-7915(95)80095-6","article-title":"Cytokine regulation of granuloma formation in schistosomiasis","volume":"7","author":"Wynn","year":"1995","journal-title":"Curr. Opin. Immunol."},{"issue":"6541","key":"10.1016\/j.vaccine.2003.07.010_BIB35","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/376594a0","article-title":"An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection","volume":"376","author":"Wynn","year":"1995","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03005930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03005930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T22:52:22Z","timestamp":1682549542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03005930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":35,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0264410X03005930"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.07.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}